RECIDA THERAPEUTICS
Recida Therapeutics is a Biotechnology company.
RECIDA THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.recidatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
650-325-5156
Total Funding:
18.57 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS GoDaddy
Similar Organizations
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Recida Therapeutics
CARB-X
CARB-X investment in Grant - Recida Therapeutics
Official Site Inspections
http://www.recidatherapeutics.com
Unable to get host informations!!!
More informations about "Recida Therapeutics"
Recida Therapeutics - Crunchbase Company Profile & Funding
Recida Therapeutics is a Biotechnology company. Where is Recida Therapeutics's headquarters? Recida Therapeutics is located in Menlo Park, California, United States. Who invested in …See details»
Recida Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Recida Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Recida Therapeutics - VentureRadar
Recida Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for serious antibiotic-resistant infections. Recida's lead program, RC-01, is a …See details»
CARB-X funds Recida Therapeutics to develop a new class of …
Recida Therapeutics is an emerging clinical-stage biotechnology company focused on developing first-in-class anti-infective medicines for the treatment of multi-drug resistant infections. The …See details»
Recida Therapeutics - Craft
Recida Therapeutics is a biopharmaceutical company focused on the development of novel-class antibiotics to address the expanding problem of multi-drug resistant gram-negative bacteria.See details»
Recida Therapeutics Inc - Company Profile and News
Recida Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on developing treatments for serious antibiotic-resistant infections.See details»
Recida Therapeutics, Inc. (Recida Therapeutics, Inc.) - 药物管线_专 …
了解Recida Therapeutics, Inc. (Recida Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 1篇新闻，药物:RC-01。See details»
Recida Therapeutics - Funding, Financials, Valuation & Investors
Recida Therapeutics is funded by 3 investors. Delian Capital and Frazier Healthcare Partners are the most recent investors. Which investors participated in the most funding rounds?See details»
Recida Therapeutics - Contacts, Employees, Board Members
Recida Therapeutics has 1 current employee profile, Co-Founder, President & CEO James Ge. Recida Therapeutics is a Biotechnology company.See details»
Frazier Healthcare Partners Launches Recida Therapeutics to …
Feb 6, 2019 · MENLO PARK, Calif.-- (BUSINESS WIRE)--Frazier Healthcare Partners today announced the launch of Recida Therapeutics, Inc., a biopharmaceutical company focused on …See details»
Frazier Healthcare Partners Launches Recida …
Frazier Healthcare Partners today announced the launch of Recida Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for serious antibiotic-resistant infections.See details»
Recida Therapeutics - Products, Competitors, Financials, …
Recida Therapeutics is a biopharmaceutical company focused on the development of therapeutics for serious antibiotic-resistant infections. Recida's program, RC-01, is a IND-stage LpxC …See details»
Recida Therapeutics Raises $8.5M in Series A - FinSMEs
Feb 9, 2019 · Recida Therapeutics, a Menlo Park, CA-based developer of novel therapeutics for serious antibiotic-resistant infections, raised $8.5M in Series A financing. The round was led …See details»
Frazier Healthcare Partners Launches Recida Therapeutics to
Feb 6, 2019 · Frazier Healthcare Partners today announced the launch of Recida Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for …See details»
CF Patients May Benefit from Recida's Goal to Treat Bacterial...
Feb 11, 2019 · Frazier Healthcare Partners has launched a new biopharmaceutical company called Recida Therapeutics, which will develop new therapies for serious antibiotic-resistant …See details»
Recida Therapeutics Launches with $8.5M Series A
Frazier Healthcare Partners today announced the launch of Recida Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for serious …See details»
Recida rolls out from Frazier Healthcare - Global Venturing
Feb 11, 2019 · Healthcare-focused venture capital firm Frazier Healthcare Partners has spun out US-based antibiotics developer Recida Therapeutics with a grant from Combating Antibiotic …See details»
Recida Therapeutics Announces the Initiation of a Phase I
Apr 1, 2019 · Recida Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class anti-infective medicines for the treatment of multidrug-resistant …See details»
Frazier Healthcare Partners launches Recida Therapeutics to …
Feb 7, 2019 · Recida’s lead program, RC-01, is a novel, IND-stage LpxC inhibitor for the treatment of multidrug-resistant gram-negative infections. Recida has licensed development …See details»
Recida Therapeutics Announces the Initiation of a Phase I Clinical ...
Apr 1, 2019 · Recida Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class anti-infective medicines for the treatment of multidrug-resistant …See details»